Guiding ATMPs to patients
Here you will find information on what is happening in Sweden in development of medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. We welcome your collaboration towards accelerated and efficacious patient solutions.
Register for ATMP Sweden 2020 in Stockholm!
Subscribe to our mailing list
Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference.
Financing ATMPs – Bedside to Reimbursement
Part 2 of our September 2019 ATMP financing events in Skåne.Read more
200 million SEK investment in Swedish gene and immunotherapy production
Cobra Biologics invests 200 million SEK in Matfors facilityRead more
Swedish based Ilya Pharma recruiting for first ATMP trial
Genetically engineered bacteria to drive wound healingRead more
Open meeting: Business models and health economics
Advanced bioreactor cultivation technology
Cell and Gene Therapy course
Work with us!
ATMP success stories
Other collaborating national projects
See all ATMP relevant organisations here